Denali Therapeutics (DNLI) EBIT Margin (QoQ) (2018 - 2023)
Denali Therapeutics (DNLI) EBIT Margin (QoQ) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Denali Therapeutics | 4.37 Bn | 4.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -903,942.00 |
| Jun 30, 2023 | 40,176.00 |
| Mar 31, 2023 | 70,964.00 |
| Dec 31, 2022 | 213,133.00 |
| Sep 30, 2022 | -306,774.00 |
| Jun 30, 2022 | 4,077.00 |
| Mar 31, 2022 | 71.00 |
| Dec 31, 2021 | 146,103.00 |
| Sep 30, 2021 | -120,743.00 |
| Jun 30, 2021 | 48,690.00 |
| Mar 31, 2021 | -97,606.00 |
| Dec 31, 2020 | 71,739.00 |
| Sep 30, 2020 | 41,415.00 |
| Jun 30, 2020 | 11.43 Mn |
| Mar 31, 2020 | -11.41 Mn |
| Dec 31, 2019 | -8,564.00 |
| Sep 30, 2019 | 38,093.00 |
| Jun 30, 2019 | -52,066.00 |
| Mar 31, 2019 | -107,035.00 |
| Dec 31, 2018 | 323,636.00 |